Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rosenbaum

Showing results (51-60 of 566) with videos related to

Pageof 57
Sort By:
Biologics : Targets & Therapy|March 7, 2014
Update on the use of systemic biologic agents in the treatment of noninfectious uveitisSirichai Pasadhika, James T Rosenbaum
Ocular Immunology and Inflammation|January 20, 2006
Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantationMichael Wertheim, James T Rosenbaum
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2019
Bugs, Drugs, and ShrugsJames T Rosenbaum, Lisa Karstens
Ocular Immunology and Inflammation|October 23, 2013
TINU (tubulointerstitial nephritis uveitis) can be associated with chorioretinal scarsAmro Ali, James T Rosenbaum
Nature Reviews. Rheumatology|October 11, 2018
The microbiome and HLA-B27-associated acute anterior uveitisJames T Rosenbaum, Mark Asquith
Current Opinion in Rheumatology|May 21, 2019
The use of biologics for uveitis associated with spondyloarthritisSruthi Arepalli, James T Rosenbaum
Clinics in Chest Medicine|January 20, 2024
Ocular SarcoidosisJames T Rosenbaum, Sirichai Pasadhika
Clinics in Chest Medicine|November 24, 2015
Ocular SarcoidosisSirichai Pasadhika, James T Rosenbaum
Current Opinion in Rheumatology|May 7, 2016
The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathiesMark Asquith, James T Rosenbaum
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Paradoxical effects of IL-10 in endotoxin-induced uveitisJ T Rosenbaum, E Angell
Pageof 57

Showing results (51-60 of 566) with videos related to

Sort By:
Pageof 57
Biologics : Targets & Therapy|March 7, 2014
Update on the use of systemic biologic agents in the treatment of noninfectious uveitisSirichai Pasadhika, James T Rosenbaum
Ocular Immunology and Inflammation|January 20, 2006
Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantationMichael Wertheim, James T Rosenbaum
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2019
Bugs, Drugs, and ShrugsJames T Rosenbaum, Lisa Karstens
Ocular Immunology and Inflammation|October 23, 2013
TINU (tubulointerstitial nephritis uveitis) can be associated with chorioretinal scarsAmro Ali, James T Rosenbaum
Nature Reviews. Rheumatology|October 11, 2018
The microbiome and HLA-B27-associated acute anterior uveitisJames T Rosenbaum, Mark Asquith
Current Opinion in Rheumatology|May 21, 2019
The use of biologics for uveitis associated with spondyloarthritisSruthi Arepalli, James T Rosenbaum
Clinics in Chest Medicine|January 20, 2024
Ocular SarcoidosisJames T Rosenbaum, Sirichai Pasadhika
Clinics in Chest Medicine|November 24, 2015
Ocular SarcoidosisSirichai Pasadhika, James T Rosenbaum
Current Opinion in Rheumatology|May 7, 2016
The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathiesMark Asquith, James T Rosenbaum
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Paradoxical effects of IL-10 in endotoxin-induced uveitisJ T Rosenbaum, E Angell
Pageof 57